The computer vision chip producer is based on research at Tsinghua University and Chinese Academy of Sciences.

University of Milan spinout Wise is a developer of low-invasive neuromodulation implants for treating pain and neurological disorders.

Creative Biosciences has collected $88m in fresh funding, five years after being founded by a Sun Yat-Sen University professor.

Group 42 and BP Ventures have co-led a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed.

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Novo Ventures and Sanofi Ventures co-led a series C round for the cancer therapy developer, which builds on work at Amsterdam UMC.

Fluke has added to $30m of series C capital raised by University of Michigan and Virginia-founded Everactive last year.

University of Utah robotics spinout Sarcos has will use the funding for the commercial manufacturing of its industrial exoskeleton product.

Tsinghua-backed Rokae is working on lightweight robots with a wide range of applications and has now raised $43.5m altogether.

UCSF spinout Mission Bio has pushed its overall funding to more than $120m following a series C round led by Novo Growth.